|
|
||||||||
Pediatric Imaging |
1 From the Department of Radiology, Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229-3039 (M.J.G., B.L.K., A.H.E., V.M.G.M., C.L.T.), and the Division of Biostatistics, University of Cincinnati Medical Center (P.S.G.). Received October 5, 1998; revision requested November 11; revision received January 6, 1999; accepted March 2. Address reprint requests to M.J.G. (e-mail: gelfand.mj@chmcc.org).
| Abstract |
|---|
|
|
|---|
MATERIALS AND METHODS: Two groups of children were examined prospectively: 124 with severe urinary tract infection, defined as patient hospitalization or a maximum temperature greater than 39.5°C, and 135 with previously diagnosed VUR. Nuclear cystography was performed in 249 patients, and fluoroscopic cystography was performed in 10. If VUR was not seen during the first cycle of bladder filling and voiding, a second cycle was performed.
RESULTS: VUR was present during cycle 1 in 40 (32%) of 124 patients with severe urinary tract infection and 90 (67%) of 135 children in the VUR follow-up group (P < .001). VUR was demonstrated during cycle 2 in seven (9%) of 76 of the severe urinary tract infection group and eight (24%) of 34 of the VUR follow-up group (P = .045). Of 15 patients with VUR during cycle 2, two had grade III VUR and 13 had grade I or II VUR.
CONCLUSION: The second cycle of cyclic cystography has a higher diagnostic yield in patients undergoing VUR follow-up than in patients with severe urinary tract infection. The decision to perform a second cycle of bladder filling and voiding should take into account the pretest probability of VUR in the child being examined.
Index terms: Bladder, radiography, 83.12177, 83.123 Children, genitourinary system, 80.21 Genitourinary system, infection, 80.21 Ureter, reflux, 82.85
| Introduction |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
The 259 children entered in this study were examined by means of nuclear or fluoroscopic cystography; 249 underwent nuclear cystography (Orbiter 7500; Siemens Gammasonics, Des Plaines, Ill) and 10 underwent fluoroscopic cystography (Advantx; GE Medical Systems, Milwaukee, Wis), with four in the severe urinary tract infection group and six in the follow-up VUR group. Nuclear cystography was performed with technetium 99m sulfur colloid prepared with use of AN sulfur colloid (0.3000.600 mCi [11.122.2 MBq]; Syncor International, Chatsworth, Calif) directly instilled into the urinary bladder via a catheter. Fluoroscopic cystography was performed with diatrizoate meglumine (Cystografin 18%; Squibb Diagnostics, Princeton, NJ) directly instilled into the urinary bladder via a catheter with the dose varying according to bladder capacity.
To control selection bias and prevent the participating physicians from enrolling only "interesting" patients in the study, the following rule was used: If any eligible cystogram was omitted from the study, all cystograms obtained on that day by using that modality (nuclear or fluoroscopic) were excluded from the study. This rule limited the number of fluoroscopic cystograms entered into the study. The patients in the two groups were not matched by age or sex.
Nuclear and fluoroscopic cystograms were obtained and graded according to previously described methods (57). Maximum bladder volume was recorded routinely for each cycle. Maximum bladder volumes for the first and second cycles were compared when VUR was present during the second cycle.
Data were analyzed by using the
2 test, the Wilcoxon signed rank test, and the Kaplan-Meier method. Using the data from the severe urinary tract infection and VUR follow-up groups, we fit a quadratic function (y = b0 + b1x + b2x2) to the data for x equal to 0, 1, and 2, where x was the number of filling cycles and y was the frequency of VUR, which was used to estimate the maximum value of y, or estimated maximal frequency of VUR, for values of x greater than 2. A P value less than .05 was considered to indicate a statistically significant difference.
| RESULTS |
|---|
|
|
|---|
In the VUR follow-up group, the first cycle demonstrated VUR in 90 (67%) of 135 patients. Of the remaining 45 patients without VUR during the first cycle, 34 underwent a second cycle, with the second cycle omitted in three because of technical problems and in eight because the child was difficult to control physically during the first cycle. Of these 34 children, eight (24%) had VUR, which yielded a frequency of VUR of 73% after two cycles. When the severe urinary tract infection and VUR follow-up groups are combined, 15 (14%) of 110 children had VUR during the second cycle.
The frequency of VUR in the VUR follow-up group was significantly higher than the frequency of VUR in the severe urinary tract infection group during the first (P < .001) and second (P = .045) cycles.
The estimated maximal frequency of VUR was 39% in the severe urinary tract infection group and 80% in the VUR follow-up group. Therefore, on the basis of these estimated frequencies, approximately 82% (32% ÷ 39%) of all children with VUR in the severe urinary tract infection group were identified after one cycle. Similarly, 84% (67% ÷ 80%) of all children with VUR in the VUR follow-up group were identified during the first cycle.
The highest grade of VUR during the second cycle was grade I in one patient, grade II in 12, and grade III in two.
In the group of 15 children who had VUR during only the second cycle, the mean maximal bladder volume during the first cycle was 276 mL, and it was 281 mL during the second cycle. The maximal bladder volume achieved during the second cycle was slightly larger than that during the first cycle (P = .063), but the median increase in bladder volume between the first and second cycles was only 10 mL.
| DISCUSSION |
|---|
|
|
|---|
Jequier and Jequier (1) and other investigators (24) demonstrated that a second cycle of bladder filling and voiding demonstrated VUR in a number of patients in whom the first cycle was normal. In the combined studies of Jequier and Jequier (1), Pozderac et al (2), Fettich and Kenda (3), and Paltiel et al (4), 14% of patients had VUR during the second cycle.
In this study, a group of patients with a 32% frequency of VUR during the first cycle (severe urinary tract infection group) had only a 9% yield of VUR during the second cycle. In contrast, a second group with a 67% frequency of VUR during the first cycle (VUR follow-up group) had a significantly greater yield of 24% during the second study (P = .045 for the second cycle).
The severe urinary tract infection group most likely is composed of three subgroups: children who have VUR with every void, children who have VUR intermittently, and children in whom VUR will never be demonstrated, even if the bladder is filled repeatedly. In the VUR follow-up group, every child had detectable VUR in the past, and the number in whom VUR is always or intermittently present can be expected to be larger than in the severe urinary tract infection group. Studies (1620) have demonstrated that slightly less than half of children with acute pyelonephritis detected at cortical scintigraphy have VUR. This may be compared with an unselected population undergoing cystography in which about 33% of the children will have VUR (5,7).
With this protocol, those who demonstrated VUR during the first cycle underwent no further examination. In the severe urinary tract infection group, however, after the first cycle there remained a relatively large number of children for whom a second cycle was necessary to look for VUR but only a small number of children who actually had intermittent VUR. This pattern was reversed in the VUR follow-up group, which had approximately the same number of children with intermittent VUR but a much smaller number of children without reflux during the first cycle.
In previous studies (14) of cyclic cystography, no attempt was made to subdivide children undergoing cystography into subpopulations with differing pretest probabilities of VUR. When this is done, the yield of VUR from a second cycle of bladder filling and voiding is significantly higher in a population with a high prevalence of VUR than in a population with a moderate prevalence of VUR. These data suggest that cyclic cystography should not be performed in all children who may have VUR but rather in subpopulations in which the diagnostic yield is high enough to justify the additional time, discomfort, fright, and radiation exposure associated with the additional cycle of bladder filling and voiding.
Groups of children with VUR differ in the frequency with which VUR is found during a single cycle of bladder filling and voiding. When cyclic cystography was performed in a population of children with a high frequency of VUR, the frequency with which VUR was detected during the second cycle was relatively high. However, the yield of VUR during the second cycle was significantly lower in a group of patients who had only a moderate frequency of VUR during the first cycle. Cyclic cystography is indicated in children who are undergoing follow-up cystography for previously documented VUR. Cyclic cystography also should be considered in other groups of children who have moderate to high pretest probabilities of VUR during the first cycle of bladder filling and voiding.
|
| Acknowledgments |
|---|
| Footnotes |
|---|
3 Current address: Department of Environmental Health, University of Cincinnati. ![]()
4 Current address: Department of Radiology, Children's Hospital, Birmingham, Ala. ![]()
Abbreviation: VUR = vesicoureteral reflux
Author contributions: Guarantor of integrity of entire study, M.J.G.; study concepts and design, M.J.G.; definition of intellectual content, M.J.G.; literature research, M.J.G.; clinical studies, M.J.G., A.H.E., V.M.G.M., B.L.K.; data acquisition, M.J.G., A.H.E., V.M.G.M., C.L.T., B.L.K.; data analysis, M.J.G., P.S.G.; statistical analysis, M.J.G., P.S.G.; manuscript preparation, M.J.G.; manuscript editing and review, M.J.G., V.M.G.M., A.H.E., B.L.K.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. B. Kenda, A. Kenig, G. Novljan, R. Ponikvar, and J. B. Ponikvar Cyclic voiding urosonography for detecting vesicoureteric reflux in renal transplant recipients Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2229 - 2231. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |